INDUSTRY FIELD GUIDE
Pharmaceutical preparation data for AI record corrections
FDA publishes questions about CGMP records and reports.
NAICS 325412 · Pharmaceutical Preparation Manufacturing
FDA publishes questions about CGMP records and reports. A pharmaceutical manufacturer can define a tightly scoped AI task around record identity, correction history and the evidence available to a reviewer. FDA records and reports questions
Create an entirely fictional batch record, a sample register and two report versions. Correct the sample identifier in the later report while preserving its recorded results. Ask the assistant to identify the effective association and show the correction chain. Include an unsigned proposed correction for another field, which the key should retain as unresolved rather than apply automatically.
Annotate batch, sample, source entry, version, correction status and evidence location. Hold out a different form layout for evaluation. Score use of a superseded record, an unsigned change treated as effective and incorrect sample association separately. The task should identify supported record relationships without authorizing product release or interpreting a result as a medical decision.
Use invented products, values and identities. Actual manufacturing records, licensed methods, customer information and laboratory documents need explicit authority for their intended use and qualified review. Describe the correction-review task and independent key in the licensing proposal. Establish the buyer's accepted sources and evaluation criteria before preparing any operating archive.
Discuss this original manufacturing sample with Fiund
Original Fiund exercise
A corrected report without a new sample
A wholly fictional administrative packet uses sample code Q9. It contains no medicine, test values, patient information or disposition.
| Record | Source | What it records |
|---|---|---|
| 1 | Sample register | Q9 registered once under batch B8. |
| 2 | Report v1 | Q9 report filed under folder F3. |
| 3 | Correction v2 | Same sample Q9; correct folder F5; v1 retained and superseded. |
Question for the model
How many samples and current reports should the index show?
Show the reference answer and checks
There is one sample, Q9, according to record 1. Record 3 replaces the current report linkage with v2/F5 and retains v1/F3 from record 2 as superseded history. No new sample, measurement, or release status is implied by this administrative correction.
- Counting report versions as samples
- Erasing the superseded report or its old reference
Fields to preserve
- sample_key
- Deduplicates across document versions
- current_report_version
- Selects effective correction
- supersession_edge
- Preserves the earlier record for traceability
Test another case
Include an unapproved proposed v3; keep v2 current until a formal effectivity record appears.
No production, pharmaceutical processing, assays, approval procedures or actual regulated documentation.
Discuss a contribution
Describe the sources you control, the task they could support and what has already been checked. Use the existing-data assessment for an archive or the collection brief for a new recording project. The contributor agreement defines Fiund’s licensing authority and compensation. A guide or fictional exercise does not establish an accepted collection or a sale.